Abano subsidiary 'forced' out by disagreeable DHB contract terms
250 jobs are on the line after Abano subsidiary pulls out of DHB contract tender.
Abano Healthcare Group [NZX: ABA] has chosen to potentially write off its $11 million pathology business rather than compete for a district health board contract on disagreeable terms.
Abano told the market today its subsidiary Aotea Pathology has withdrawn its bid to provide pathology services
Want to read more? It's easy.
Choose your best value subscription option
Individual
Group membership
NBR Marketplace
Yearly Premium Online Subscription
NZ$499.00 / yearly
Monthly Premium Online Subscription
NZ$44.95 / monthly
Smartphone Only Subscription
NZ$24.95 / monthly
Premium Group Membership 10 Users
NZ$350+GST / monthly
$35 per user - Pay by monthly credit card debitPremium Group Membership 20 Users
NZ$600+GST / monthly
$30 per user - Pay by monthly credit card debitPremium Group Membership 50 Users
NZ$1250+GST / monthly
$25 per user - Pay by monthly credit card debitPremium Group Membership 100 Users
NZ$1875+GST / monthly
$18.75 per user - Pay by monthly credit card debitYearly Premium Online Subscription + NBR Marketplace
NZ$499.00 / yearly
Already have an account? Login
Calida Smylie
Mon, 02 Feb 2015
Mon, 02 Feb 2015
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Abano subsidiary 'forced' out by disagreeable DHB contract terms
44819